G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 10, 2021 at 02:20 am IST
Share
G&E Herbal Biotechnology Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 3.626 million compared to TWD 5.121 million a year ago. Operating loss was TWD 4.613 million compared to TWD 5.601 million a year ago. Net loss was TWD 4.637 million compared to TWD 5.109 million a year ago. Basic loss per share was TWD 0.08 compared to TWD 0.09 a year ago. For the half year, sales was TWD 11.852 million compared to TWD 9.147 million a year ago. Operating loss was TWD 8.359 million compared to TWD 9.498 million a year ago. Net loss was TWD 7.969 million compared to TWD 9.043 million a year ago. Basic loss per share was TWD 0.14 compared to TWD 0.16 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.